LICENSE AGREEMENTLicense Agreement • August 9th, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This License Agreement (this “License Agreement”) is made and entered into as of August 3, 2023 (the “Effective Date”), by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Licensor”), on the one hand, and ResolutionRx Ltd, a company organized under the laws of Australia (the “Licensee”), on the other hand. For convenience, Licensor and Licensee may be referred to herein individually as a “Party” and collectively as the “Parties”.
MASTER INTERCOMPANY SERVICES AGREEMENTMaster Intercompany Services Agreement • August 9th, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This Master Intercompany Services Agreement (“Agreement”) is entered into as of August 3, 2023, by and between RespireRX Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (“Provider”), and ResolutionRx Ltd., an Australian company (“Recipient”). Provider and Recipient may each individually be referred to as a “Party” and collectively referred to as the “Parties”.
SUBLICENSE AGREEMENTExclusive License Agreement • August 9th, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Illinois
This Sublicense Agreement (this “Sublicense Agreement”) is made and entered into as of August 3, 2023 (the “Effective Date”), by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (“RespireRx” or the “Sublicensor”), on the one hand, and ResolutionRx Ltd., a company organized under the laws of Australia (the “Sublicensee”), on the other hand. For convenience, Sublicensor and Sublicensee may be referred to herein individually as a “Party” and collectively as the “Parties”.
STOCK TRANSFER AGREEMENTLicense Agreement • August 9th, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This share transfer Agreement (the “Agreement”) sets out the terms and conditions upon which ResolutionRx Ltd (the “Transferor”), being a Company duly organized under the laws of Australia with Australian Business Number (ABN) 17 664 925 651 and having its registered address at GP Box 939, Adelaide, SA 5001, will transfer certain shares held by Transferor to RespireRx Pharmaceuticals Inc., a Delaware corporation with tax identification number 33-0303583 (the “Transferee”), having its address at 1226 Valley Road, Suite C, Glen Rock, NJ 074452 (together, the “Parties”).
